Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Burkitt Lymphoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 11Rituximab 9Cyclophosphamide 8fludarabine phosphate 7Mycophenolic Acid 5Filgrastim 5Etoposide 5Cyclosporine 5Radiotherapy 4Whole-Body Irradiation 3Methotrexate 3Ifosfamide 3Busulfan 3Bortezomib 3ibritumomab tiuxetan 2Tacrolimus 2Paclitaxel 2Melphalan 2Lenalidomide 2Indium 2Gene Expression Profiling 2Gemcitabine 2Cord Blood Stem Cell Transplantation 2Carboplatin 2Bendamustine Hydrochloride 2Antilymphocyte Serum 2veliparib 1romidepsin 1ocaratuzumab 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Lymphoma, Large-Cell, Immunoblastic × Teniposide × Clear all
NCT00004916 2012-06-06

Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Northwestern University

Phase 1/2 Completed
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡